Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study.

Bilgic A, Kodjikian L, Srivastava S, Dwivedi S, Banker AS, Abukashabah A, Sudhalkar A, Mathis T

DOI: 10.3390/jcm10184153
Published: 2021 Sep 15
Container: Journal of clinical medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/jcm10184153,
  title = {Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study.},
  author = {Bilgic A and Kodjikian L and Srivastava S and Dwivedi S and Banker AS and Abukashabah A and Sudhalkar A and Mathis T},
  year = {2021},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm10184153},
  url = {https://doi.org/10.3390/jcm10184153}
}

RIS

TY  - JOUR
TI  - Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study.
AU  - Bilgic A
AU  - Kodjikian L
AU  - Srivastava S
AU  - Dwivedi S
AU  - Banker AS
AU  - Abukashabah A
AU  - Sudhalkar A
AU  - Mathis T
PY  - 2021
JO  - Journal of clinical medicine
DO  - 10.3390/jcm10184153
UR  - https://doi.org/10.3390/jcm10184153
ER  -

APA

A, B., L, K., S, S., S, D., AS, B., A, A., A, S., & T, M. (2021). Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study.. Journal of clinical medicine. https://doi.org/10.3390/jcm10184153

Source records

pubmed · retrieved 2026-09-26T07:06:47.088Z